Iol Chemcials And Pharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd., commonly referred to as IOL Chemicals, is a prominent player in the pharmaceutical and chemical industry, headquartered in Punjab, India. Established in 1986, the company has made significant strides in the production of bulk drugs, intermediates, and specialty chemicals, catering to both domestic and international markets. With a strong focus on quality and innovation, IOL Chemicals offers a diverse range of products, including active pharmaceutical ingredients (APIs) and various chemical intermediates. Their commitment to sustainable practices and advanced manufacturing processes sets them apart in a competitive landscape. Recognised for their robust market position, IOL Chemicals has achieved notable milestones, including certifications from global regulatory bodies, which underscore their dedication to excellence and compliance. As a trusted supplier, IOL Chemicals continues to contribute to the evolving needs of the pharmaceutical sector.
DitchCarbon Score
How does Iol Chemcials And Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Iol Chemcials And Pharmaceuticals's score of 49 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Iol Chemcials And Pharmaceuticals's reported carbon emissions
In 2024, IOL Chemicals and Pharmaceuticals reported total carbon emissions of approximately 175.3 million tonnes CO2e. This figure includes about 49.5 million tonnes from Scope 1 emissions, 6.2 million tonnes from Scope 2, and a significant 119.6 million tonnes from Scope 3 emissions. The company has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its entire value chain by FY2050. In the near term, IOL Chemicals and Pharmaceuticals plans to reduce its absolute Scope 1 and 2 emissions by 58.8% by FY2033, using FY2022 as the baseline year. Additionally, the company targets a 35% reduction in absolute Scope 3 emissions within the same timeframe. For the long term, the goals include a 90% reduction in both Scope 1 and 2 emissions and Scope 3 emissions by FY2050, again referencing FY2022 as the baseline. These commitments align with industry standards and reflect a proactive approach to addressing climate change, demonstrating IOL Chemicals and Pharmaceuticals' dedication to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 24,928,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 1,171,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 779,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Iol Chemcials And Pharmaceuticals is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
